International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009.
about
New Diagnostic Strategies in Infection Safety: The (R)evolution?Genetic variation of occult hepatitis B virus infectionAutomated Triplex (HBV, HCV and HIV) NAT Assay Systems for Blood Screening in IndiaTransfusion transmission of HCV, a long but successful road map to safetyPathogen inactivation technologies for cellular blood components: an updateAPASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing.Routine screening of blood donations at Qingdao central blood bank, China, for hepatitis B virus (HBV) DNA with a real-time, multiplex nucleic acid test for HBV, hepatitis C virus, and human immunodeficiency virus Types 1 and 2.A pilot study on screening blood donors with individual-donation nucleic acid testing in China.Sufficient blood, safe blood: can we have both?Hepatitis B and C virus infections among patients with end stage renal disease in a low-resourced hemodialysis center in Vietnam: a cross-sectional study.Occult hepatitis B virus infection and blood transfusionA Cross-Sectional Study on Burden of Hepatitis C, Hepatitis B, HIV and Syphilis in Multi-Transfused Thalassemia Major Patients Reporting to a Government Hospital of Central India.Introducing Pathogen Reduction Technology in Poland: A Cost-Utility AnalysisThe potential complexity and need for caution when interpreting atypical human immunodeficiency virus reactivity in blood donors.Need for nucleic Acid testing in countries with high prevalence of transfusion-transmitted infections.Blood donor deferral policies across Europe and characteristics of men who have sex with men screened for human immunodeficiency virus in blood establishments: data from the European Men-who-have-sex-with-men Internet Survey (EMIS).Sensitivity of hepatitis C virus core antigen and antibody combination assays in a global panel of window period samplesPrevalence of antibody to Hepatitis B core antigen and Hepatitis B virus DNA in HBsAg negative healthy blood donors.Recent Advances in Preventing Adverse Reactions to TransfusionMolecular virology in transfusion medicine laboratory.Hepatitis B virus infection among first-time blood donors in Italy: prevalence and correlates between serological patterns and occult infectionImplementation of an HIV-1 Triple-Target NAT Assay in the Routine Screening at Three German Red Cross Blood Centres.Human Immunodeficiency Virus (HIV).One window-period donation in two years of individual donor-nucleic acid test screening for hepatitis B, hepatitis C and human immunodeficiency virus.Prevalence of HBV DNA among 20 million seronegative blood donations in China from 2010 to 2015The results of nucleic acid testing in remunerated and non-remunerated blood donors in Lithuania.Factors in enhancing blood safety by nucleic acid technology testing for human immunodeficiency virus, hepatitis C virus and hepatitis B virus.Risk Minimization Measures for Blood Screening HIV-1 Nucleic Acid Amplification Technique Assays in Germany.Emerging Pathogens - How Safe is Blood?Molecular HIV screening.Current testing strategies for hepatitis C virus infection in blood donors and the way forwardAdvances in multiplex nucleic acid diagnostics for blood-borne pathogens: promises and pitfalls.Comparison of multiplex PCR hybridization-based and singleplex real-time PCR-based assays for detection of low prevalence pathogens in spiked samples.What weighs more-low compliance with self-deferral or minor medical procedures? Explaining the high rate of hepatitis C virus window-period donations in Poland.Contrasting HCV and HIV seroepidemiology in 11 years of blood donors screening in Brazil.The characteristics of hepatitis B surface antigen (HBsAg)-negative hepatitis B virus (HBV) infection in Chinese blood donors: a follow-up study of donors tested negative for HBsAg and reactive for simultaneous nucleic acid testing of HBV, hepatitisTwo decades of risk factors and transfusion-transmissible infections in Dutch blood donors.Multiplex detection and identification of viral, bacterial, and protozoan pathogens in human blood and plasma using a high-density resequencing pathogen microarray platform.[Human immunodeficiency virus: position of Blood Working Group of the Federal Ministry of Health].Occult Hepatitis Infection in Transfusion Medicine: Screening Policy and Assessment of Current Use of Anti-HBc Testing
P2860
Q26700047-7E382A45-559E-41CE-B08C-278A983E347EQ26751031-A31398D6-6D89-48BA-BB51-96834A0C0433Q26752681-193CEA4E-3B93-4DC3-B546-C211DF37EF36Q26865471-12C5E40E-C649-45CD-87FD-EF210E27B662Q28655769-8EFEA242-C01D-41D7-AB9F-93EC791B7EC0Q30250088-523C8BE1-C8F6-4BB0-B921-77D45A1BA097Q33455459-CCD0269E-0029-4F8A-8D48-3EB6E98735ACQ33690837-A6A1793B-6F2F-488A-A14A-A2773C5F35A0Q34206713-23D3A354-61C5-4A86-9403-86E3C97417E9Q35141866-D1817B7F-D68E-4AAC-8217-4B0297A4E3A9Q35237335-10987D52-F08A-4F67-8509-6F84ADACCBBCQ35736954-52D2B5C6-6337-4B97-A7E4-9C7DBE8AA4E6Q35789569-3371D569-7335-46EB-AF73-CAB663AAECAEQ36220101-7CEB8354-E01B-416F-AA0E-F646284275C2Q36248372-0B85FAEF-F0B8-4C66-AEB6-7EFC360EA5DEQ36367719-C31CD548-14AC-4CBC-9648-FF50A84F52EFQ36554189-4BD26011-2B90-42AA-98D0-B361E5C9B780Q36654281-1FBA3FCB-1687-47A6-80E5-E71B52077C5AQ36750167-9108FEE2-FFB8-4A9B-B0E2-DC2C7CA22C7AQ36766449-D471FFFF-DC34-4BCF-B5D3-418BFCF2AC1AQ36766479-09C236C9-13E4-4864-83CB-6FCBFBED997CQ37045800-33E4E6C7-45F8-472A-9C00-C49510046483Q37045832-842DE051-CFEB-40CB-B4C7-0A6017D30C2CQ37057009-6646D5BD-6D5C-4EDA-865E-648A28AA2E82Q37408535-5792A8BA-00EB-421B-B4EF-BA664FB79706Q37602352-9AA84390-D923-41A2-A5F3-DAB16E2EABCDQ37618604-F679C66C-F668-433C-B935-3FFA2F04B67EQ37630304-A05B136E-4BC1-4338-9AB8-8790A3C4CEA0Q37630317-2DCC25B6-D682-4696-9111-3AA6EEE93F06Q38142249-020402E8-5C67-45D3-9250-3ED1C135A21CQ38198619-EFA41B5D-8FA1-44D5-969F-31683F75E9DBQ38637507-A01500FB-D330-4F43-A9AF-32D97CB740F6Q40080300-2CCB173B-7B0A-4DCA-A947-4322E0053C2AQ40181372-A6CE590B-FB3F-4C99-A8BB-9EA373F9807EQ40194957-4549C822-0FA2-4C59-938A-642BAFF67C1BQ40344145-353C24D8-CE7F-49B6-AEB7-D04B13E15B2CQ40555519-821572C3-F1D0-499E-9F53-AEACAB6AC5FFQ40771276-A3C97529-7197-4E97-8819-606D9C83E37CQ40942917-25194AB2-A525-46E8-82B2-A5146AFABDF4Q41111337-46E4D5F8-1F50-4656-959E-6980C1C32B2E
P2860
International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
International survey on NAT te ...... n and yield from 1999 to 2009.
@en
International survey on NAT te ...... n and yield from 1999 to 2009.
@nl
type
label
International survey on NAT te ...... n and yield from 1999 to 2009.
@en
International survey on NAT te ...... n and yield from 1999 to 2009.
@nl
prefLabel
International survey on NAT te ...... n and yield from 1999 to 2009.
@en
International survey on NAT te ...... n and yield from 1999 to 2009.
@nl
P2093
P50
P1433
P1476
International survey on NAT te ...... n and yield from 1999 to 2009.
@en
P2093
A Gottreich
A Schuller
C Jennings
P356
10.1111/J.1423-0410.2011.01506.X
P577
2011-09-21T00:00:00Z